Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shin

Showing results (541-550 of 1,059) with videos related to

Pageof 106
Sort By:
Journal of General Internal Medicine|September 19, 2019
A Comparison of Online Physician Ratings and Internal Patient-Submitted Ratings from a Large Healthcare SystemKanu Okike, Natalie R Uhr, Sherry Y M Shin, et al.
Head & Neck|April 11, 2012
Laryngeal tumor volume as a predictor for thyroid cartilage penetrationSvetlana S Kats, Susan Muller, Ashley Aiken, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 3, 2009
The clinical course of respiratory tuberculosis in lung cancer patientsS-I Cha, K-M Shin, J-W Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2005
Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neckRoy S Herbst, Matthew Arquette, Dong M Shin, et al.
Transplantation Proceedings|October 26, 2013
Comparison of the incidence of de novo malignancy in liver or kidney transplant recipients: analysis of 2673 consecutive cases in a single centerM Shin, H H Moon, J M Kim, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 6, 1998
Phase II trial of recombinant IFN-alpha2a with etoposide/cisplatin induction and interferon/megestrol acetate maintenance in extensive small cell lung cancerF R Khuri, F V Fossella, J S Lee, et al.
Plos Pathogens|October 1, 2020
Periodontal pathogens promote cancer aggressivity via TLR/MyD88 triggered activation of Integrin/FAK signaling that is therapeutically reversible by a probiotic bacteriocinPachiyappan Kamarajan, Islam Ateia, Jae M Shin, et al.
STAR Protocols|December 20, 2022
CyTOF protocol for immune monitoring of solid tumors from mouse modelsSarah M Shin, Alexei Hernandez, Erin Coyne, et al.
Transplantation Proceedings|October 26, 2013
Importance of donor-recipient age gradient to the prediction of graft outcome after living donor liver transplantationM Shin, H H Moon, J M Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Treatment of patients with small-cell lung cancer refractory to etoposide and cisplatin with the topoisomerase I poison topotecanR Perez-Soler, B S Glisson, J S Lee, et al.
Pageof 106

Showing results (541-550 of 1,059) with videos related to

Sort By:
Pageof 106
Journal of General Internal Medicine|September 19, 2019
A Comparison of Online Physician Ratings and Internal Patient-Submitted Ratings from a Large Healthcare SystemKanu Okike, Natalie R Uhr, Sherry Y M Shin, et al.
Head & Neck|April 11, 2012
Laryngeal tumor volume as a predictor for thyroid cartilage penetrationSvetlana S Kats, Susan Muller, Ashley Aiken, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|September 3, 2009
The clinical course of respiratory tuberculosis in lung cancer patientsS-I Cha, K-M Shin, J-W Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 13, 2005
Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neckRoy S Herbst, Matthew Arquette, Dong M Shin, et al.
Transplantation Proceedings|October 26, 2013
Comparison of the incidence of de novo malignancy in liver or kidney transplant recipients: analysis of 2673 consecutive cases in a single centerM Shin, H H Moon, J M Kim, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|May 6, 1998
Phase II trial of recombinant IFN-alpha2a with etoposide/cisplatin induction and interferon/megestrol acetate maintenance in extensive small cell lung cancerF R Khuri, F V Fossella, J S Lee, et al.
Plos Pathogens|October 1, 2020
Periodontal pathogens promote cancer aggressivity via TLR/MyD88 triggered activation of Integrin/FAK signaling that is therapeutically reversible by a probiotic bacteriocinPachiyappan Kamarajan, Islam Ateia, Jae M Shin, et al.
STAR Protocols|December 20, 2022
CyTOF protocol for immune monitoring of solid tumors from mouse modelsSarah M Shin, Alexei Hernandez, Erin Coyne, et al.
Transplantation Proceedings|October 26, 2013
Importance of donor-recipient age gradient to the prediction of graft outcome after living donor liver transplantationM Shin, H H Moon, J M Kim, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1996
Treatment of patients with small-cell lung cancer refractory to etoposide and cisplatin with the topoisomerase I poison topotecanR Perez-Soler, B S Glisson, J S Lee, et al.
Pageof 106